Status:
UNKNOWN
The Effect of the ALDH2 Gene Polymorphism on the Propofol Potency for Inducing Loss of Consciousness
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Propofol
Eligibility:
MALE
50-75 years
Brief Summary
The aim of this study is to determine whether ALDH2 gene polymorphisms (G/G, G/A A/A) have effect on the potency of propofol.
Eligibility Criteria
Inclusion
- ASA II
Exclusion
- ASA III-IV
- OSAS
- hepatic and renal insufficiency
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03762538
Start Date
February 1 2019
End Date
December 31 2019
Last Update
December 3 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.